Episode 830: OpenAI & AMD Deal is Too Suspicious. Ambarella & Monopar therapeutics Analysis

The Shkreli Pill - A podcast by Urban Tapes

Podcast artwork

Categories:

In this episode, Martin examines a deal between OpenAI and AMD that he views as unusually suspicious, exploring its possible implications for the market. He also provides detailed analysis of Ambarella and Monopar Therapeutics, outlining the key factors shaping his outlook on both stocks.

Visit the podcast's native language site